[1]
Nickel, J.C. et al. 2023. MV140 sublingual vaccine reduces recurrent urinary tract infection in women: Results from the first North American clinical experience study. Canadian Urological Association Journal. 18, 2 (Oct. 2023), 25–31. DOI:https://doi.org/10.5489/cuaj.8455.